CYFD says the report, which found the agency made less progress in 2023 than 2022, did not do the department justice.

Revenue: US$253.6k (up 14% from 3Q 2023). Net loss: US$1.72m (loss widened by 11% from 3Q 2023). US$0.99 loss per share. All ...

It is known for its commitment to improving health and well-being through a wide array of products and services. The company operates in three main sectors: Pharmaceuticals, Medical Devices, and ...